This grant funds the validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, treatment response, and prevention, supporting both analytical and clinical validation phases.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.
This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.
This grant supports researchers analyzing All of Us biospecimens to study biomarkers and chronic diseases, contributing new data to advance precision medicine and broaden research resources.
Acceleration to Clinic Grant supports investigator teams validating ovarian cancer biomarkers, pairing research funding with expert advice to advance early detection or interception toward clinical use.